Bridgeway Capital Management’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.9K | Sell |
26,700
-93,800
| -78% | -$52.4K | ﹤0.01% | 1169 |
|
2025
Q1 | $57.4K | Sell |
120,500
-129,200
| -52% | -$61.5K | ﹤0.01% | 1112 |
|
2024
Q4 | $252K | Sell |
249,700
-7,900
| -3% | -$7.98K | 0.01% | 959 |
|
2024
Q3 | $440K | Buy |
257,600
+100,000
| +63% | +$171K | 0.01% | 893 |
|
2024
Q2 | $402K | Buy |
157,600
+40,000
| +34% | +$102K | 0.01% | 909 |
|
2024
Q1 | $492K | Sell |
117,600
-2,500
| -2% | -$10.5K | 0.01% | 937 |
|
2023
Q4 | $399K | Sell |
120,100
-44,900
| -27% | -$149K | 0.01% | 995 |
|
2023
Q3 | $330K | Hold |
165,000
| – | – | 0.01% | 998 |
|
2023
Q2 | $521K | Buy |
+165,000
| New | +$521K | 0.01% | 884 |
|